Search Results

Return to List
Results 1–3 of 3
Title Date
1.

Magnesium Sulfate Use in Obstetrics

Number 652

(Reaffirmed 2016. Replaces Committee Opinion Number 573, September 2013)

ABSTRACT The US Food and Drug Administration advises against the use of magnesium sulfate injections for more than 57 days to stop preterm labor in pregnant women Based on this the drug classification was changed from Category A to Category D and the labeling was changed to include this new warnin...

January 2016

PDF Format
2.

The Obstetric and Gynecologic Hospitalist

Number 657

(Replaces Committee Opinion Number 459, July 2010)

ABSTRACT The term hospitalist refers to physicians whose primary professional focus is the general medical care of hospitalized patients Their activities may include patient care teaching research and inpatient leadership The American College of Obstetricians and Gynecologists supports the continu...

February 2016

PDF Format
3.

Refusal of Medically Recommended Treatment During Pregnancy

Number 664

(Replaces Committee Opinion Number 321, November 2005)

ABSTRACT One of the most challenging scenarios in obstetric care occurs when a pregnant patient refuses recommended medical treatment that aims to support her wellbeing her fetuss wellbeing or both In such circumstances the obstetriciangynecologists ethical obligation to safeguard the pregnant wom...

June 2016

PDF Format

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998